INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title:
Treatment Of Active Pulmonary And Extra-Pulmonary Tuberculosis with Co-morbidities in Adult Patients Admitted to The Government Tertiary Care Hospital in Mandya: A Cross-Sectional Study
Authors Name:
DR. AJAY GOPINATH
, KAVITHA SEKAR , MADEEHA ABRAR , MIDHUNA T , DR. BLESSIN V SHERVIN
Tuberculosis (TB) has been a health problem that, despite all global efforts, they claimed 1.3 million deaths globally in 2020, with an increase to 1.4 million people in 2021. Due to difficulty in diagnosis and treatment of TB cases during Coronavirus pandemic in 2019, it reversed years of progress in the field. Tuberculosis is communicable disease caused by the bacteria Mycobacterium tuberculosis which commonly affects the lungs. The treatment of tuberculosis is complicated by many factors, and it is very crucial to evaluate the effectiveness of drug therapy to improve the quality of life for the tuberculosis patients. Adults who are suffering with multiple disease states are known to suffer more from tuberculosis infection hence, an appropriate treatment must be provided for such patients. The main objective of the study is to enhance the knowledge regarding tuberculosis’s association with co-morbidities. And also, to describe the treatment pattern involved in it. In a tertiary care hospital, a cross sectional study was conducted for a duration of 6 months which involved 90 tuberculosis affected patients with various co-morbidities. The study assesses the presence of different co-morbidities and their treatment pattern in the individual patient by collecting the data from the patient’s medical record. Statistical analysis i.e., descriptive analysis was done. The primary outcomes were to assess the prescribed drugs for the treatment of active pulmonary (PTB) and extra-pulmonary tuberculosis (EPTB) and secondary outcomes were focused on the association of tuberculosis with co-morbidities and their treatment pattern. The present study showed that among 90 patients, 30% of patients had extra-pulmonary tuberculosis and 70% of patients had pulmonary tuberculosis. The majority of the co-morbidities with tuberculosis were under respiratory system-related diseases (48.8%). Most of the patients were with anaemia (35.5%). In conclusion, co-morbidities are present in many tuberculosis patients and are associated with poor quality of life and increased morbidity. Identification and correction of co-morbidities is based on treating the underlying cause which may improve their clinical outcome.
Keywords:
Tuberculosis, Extra pulmonary tuberculosis, Comorbidities, National Tuberculosis Elimination Programme (NTEP), World Health Organization (WHO).
Cite Article:
"Treatment Of Active Pulmonary And Extra-Pulmonary Tuberculosis with Co-morbidities in Adult Patients Admitted to The Government Tertiary Care Hospital in Mandya: A Cross-Sectional Study", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 11, page no.b301-b307, November-2023, Available :http://www.ijnrd.org/papers/IJNRD2311139.pdf
Downloads:
000118756
ISSN:
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Facebook Twitter Instagram LinkedIn